Ardent Health Partners (NYSE:ARDT) Releases Quarterly Earnings Results, Beats Estimates By $0.31 EPS

Ardent Health Partners (NYSE:ARDTGet Free Report) issued its earnings results on Wednesday. The company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31, Zacks reports. The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion. Ardent Health Partners updated its FY 2025 guidance to 1.730-2.010 EPS.

Ardent Health Partners Stock Down 5.6 %

Ardent Health Partners stock traded down $0.86 during midday trading on Friday, reaching $14.31. The stock had a trading volume of 211,776 shares, compared to its average volume of 382,772. Ardent Health Partners has a 52-week low of $13.55 and a 52-week high of $20.72. The company has a fifty day moving average of $15.23 and a 200 day moving average of $16.84. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91.

Analyst Ratings Changes

ARDT has been the topic of a number of research reports. Truist Financial reduced their price objective on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada restated an “outperform” rating and issued a $23.00 price target on shares of Ardent Health Partners in a research report on Thursday, November 14th. Stephens reiterated an “overweight” rating and set a $22.00 price objective on shares of Ardent Health Partners in a research report on Thursday. JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a report on Tuesday, December 17th. Finally, Leerink Partners upped their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research report on Tuesday, November 12th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $21.36.

Check Out Our Latest Stock Analysis on Ardent Health Partners

About Ardent Health Partners

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Further Reading

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.